Merck & Co Inc. (NYSE:MRK)
Investor Briefing at 2017 ASCO Annual Meeting Call
June 5, 2017 18:45 ET
Executives
Teri Loxam - Investor Relations
Roger Perlmutter - President, Merck Research Labs
Frank Clyburn - President, Global Oncology
Analysts
Dave Risinger - Morgan Stanley
Jami Rubin - Goldman Sachs
Chris Schott - JPMorgan
Gregg Gilbert - DB
Alex Arfaei - BMO Capital Markets
Seamus Fernandez - Leerink Partners
Paul Choi - Barclays